iShares Health Innovation Active ETF (NYSEARCA:BMED) Sees Significant Decline in Short Interest

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the recipient of a significant decline in short interest in the month of August. As of August 14th, there was short interest totaling 2,154 shares, a decline of 73.2% from the July 30th total of 8,033 shares. Based on an average daily trading volume, of 2,286 shares, the short-interest ratio is presently 0.9 days. Approximately 0.6% of the company’s shares are sold short.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in iShares Health Innovation Active ETF stock. Comprehensive Financial Planning Inc. PA bought a new stake in shares of iShares Health Innovation Active ETF (NYSEARCA:BMED) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 10,832 shares of the company’s stock, valued at approximately $309,000. Comprehensive Financial Planning Inc. PA owned approximately 3.01% of iShares Health Innovation Active ETF at the end of the most recent quarter.

iShares Health Innovation Active ETF Stock Performance

BMED stock traded down $0.15 on Thursday, reaching $34.50. The company’s stock had a trading volume of 1,036 shares, compared to its average volume of 3,428. The business has a fifty day simple moving average of $31.34 and a two-hundred day simple moving average of $29.80. iShares Health Innovation Active ETF has a 12-month low of $25.79 and a 12-month high of $34.86. The firm has a market cap of $12.42 million, a PE ratio of 24.91 and a beta of 0.73.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.